Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Enza Biotech AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -4,298 Less Arrow -5,981 More Arrow -5,777
EBITDA -4,121 Less Arrow -5,570 More Arrow -5,365
Total assets 5,131 Less Arrow 3,717 Less Arrow 3,677
Current assets 5,131 Less Arrow 1,548 Less Arrow 1,211
Current liabilities 1,011 More Arrow 1,190 Less Arrow 693
Equity capital 4,120 Less Arrow 2,527 More Arrow 2,984
- share capital 179 More Arrow 185 Less Arrow 184
Employees (average) 5 Equal arrow 5 Equal arrow 5

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 80.3% Less Arrow 68.0% More Arrow 81.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -83.8% Less Arrow -160.9% More Arrow -157.1%
Current ratio 507.5% Less Arrow 130.1% More Arrow 174.7%
Return on equity (ROE) -104.3% Less Arrow -236.7% More Arrow -193.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.